Variant report
Variant | nsv516219 |
---|---|
Chromosome Location | chr2:35022419-35033996 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:10)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:10 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr2:35028378-35028458 | GM13976 | blood: | n/a | n/a |
2 | CTCF | chr2:35028761-35028786 | Kidney_OC | kidney: | n/a | n/a |
3 | CTCF | chr2:35031642-35031715 | Kidney_OC | kidney: | n/a | n/a |
4 | FOXA2 | chr2:35026638-35027075 | A549 | lung: | n/a | n/a |
5 | JUND | chr2:35023816-35023819 | H1-hESC | embryonic stem cell: | n/a | n/a |
6 | MAZ | chr2:35024477-35024522 | HepG2 | liver: | n/a | n/a |
7 | POLR2A | chr2:35026136-35026304 | H1-hESC | embryonic stem cell: | n/a | n/a |
8 | POLR2A | chr2:35023284-35023446 | MCF10A-Er-Src | breast: | n/a | n/a |
9 | STAT3 | chr2:35024388-35024852 | MCF10A-Er-Src | breast: | n/a | n/a |
10 | STAT3 | chr2:35023736-35024111 | MCF10A-Er-Src | breast: | n/a | n/a |
No data |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-CRIM1-1 | chr2:35024917-35024966 | XLOC_001425 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000226994 | TF binding region |
NAP1L1 | miRNA target sites |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs1898667 | chr2:35022419-35022420 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs569702291 | chr2:35022425-35022426 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs13418932 | chr2:35022471-35022472 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs564180275 | chr2:35022476-35022477 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs79749444 | chr2:35022564-35022565 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs566119497 | chr2:35022565-35022566 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs554719251 | chr2:35022572-35022573 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs13393488 | chr2:35022583-35022584 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs554720062 | chr2:35022597-35022598 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs67565342 | chr2:35022619-35022620 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs565514979 | chr2:35022627-35022628 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs537326282 | chr2:35022649-35022650 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs557036369 | chr2:35022656-35022657 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs576901639 | chr2:35022723-35022724 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs577327097 | chr2:35022779-35022780 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs541714877 | chr2:35022810-35022811 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs545734640 | chr2:35022848-35022849 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs559190013 | chr2:35022855-35022856 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs572859492 | chr2:35022893-35022894 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs376573677 | chr2:35022896-35022897 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs541288903 | chr2:35022913-35022914 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs561126842 | chr2:35022919-35022920 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs530363207 | chr2:35023021-35023022 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs148116088 | chr2:35023037-35023038 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs183579969 | chr2:35023073-35023074 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs559591958 | chr2:35023094-35023095 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs532404960 | chr2:35023119-35023120 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs552504090 | chr2:35023164-35023165 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs566061324 | chr2:35023168-35023169 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs77716623 | chr2:35023202-35023203 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs370045377 | chr2:35023224-35023225 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs9941551 | chr2:35023231-35023232 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs141913509 | chr2:35023250-35023251 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs150614810 | chr2:35023449-35023450 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs139069729 | chr2:35023474-35023475 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs577165910 | chr2:35023481-35023482 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs188627155 | chr2:35023538-35023539 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs72795074 | chr2:35023550-35023551 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs572882534 | chr2:35023561-35023562 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs143302345 | chr2:35023612-35023613 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs561190338 | chr2:35023642-35023643 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs147540815 | chr2:35023707-35023708 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs77914900 | chr2:35023784-35023785 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs563650165 | chr2:35023802-35023803 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs534715584 | chr2:35023812-35023813 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs115077507 | chr2:35023832-35023833 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs559682111 | chr2:35023875-35023876 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs528617906 | chr2:35023900-35023901 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs3925971 | chr2:35023963-35023964 | Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs568517507 | chr2:35024027-35024028 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17393978 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Breast cancer | 17603634 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Bladder cancer | 21909424 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 19521722 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21364760 | CNVD |
Wilms tumour | 21544195 | CNVD |
Non-small cell lung cancer | 18927303 | CNVD |
Hereditary gingival fibromatosis | 19633868 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 21045282 | CNVD |
Prostate cancer | 21965145 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Neurocytoma | 17123091 | CNVD |
Autism | 22495309 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
small cell lung cancer | 20016488 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:35021200-35025600 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
2 | chr2:35021200-35035400 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr2:35024600-35025000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
4 | chr2:35025600-35026000 | Enhancers | HUES6 Cell Line | embryonic stem cell |
5 | chr2:35025800-35026200 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
6 | chr2:35029400-35029600 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
7 | chr2:35029600-35046600 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
8 | chr2:35031000-35031800 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
9 | chr2:35031400-35031800 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
10 | chr2:35031400-35032800 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
11 | chr2:35031400-35032800 | Enhancers | NHEK | skin |
12 | chr2:35031800-35032600 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
13 | chr2:35032600-35033800 | Enhancers | Breast Myoepithelial Primary Cells | Breast |